Bridgefront Capital, LLC Ionis Pharmaceuticals Inc Transaction History
Bridgefront Capital, LLC
- $236 Million
- Q2 2024
A detailed history of Bridgefront Capital, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bridgefront Capital, LLC holds 5,559 shares of IONS stock, worth $222,693. This represents 0.11% of its overall portfolio holdings.
Number of Shares
5,559Holding current value
$222,693% of portfolio
0.11%Shares
6 transactions
Others Institutions Holding IONS
# of Institutions
394Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$555 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$506 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$413 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$331 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$263 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.69B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...